Skip to main content

Deserpidine / methyclothiazide Pregnancy and Breastfeeding Warnings

Brand names: Enduronyl, Enduronyl Forte

Deserpidine / methyclothiazide Pregnancy Warnings

Deserpidine-methyclothiazide has been assigned to pregnancy category C by the FDA. Animal studies have not been conducted. There are no controlled data in human pregnancy. Deserpidine-methyclothiazide should only be given during pregnancy when need has been clearly established.

See references

Deserpidine / methyclothiazide Breastfeeding Warnings

Deserpidine and methyclothiazide are excreted into human milk. The manufacturer recommends that due to the potential for serious adverse reactions in nursing infants, a decision should be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.

See references

References for pregnancy information

  1. Product Information. Enduronyl (deserpidine-methyclothiazide). Abbott Pharmaceutical. 2001;PROD.

References for breastfeeding information

  1. Product Information. Enduronyl (deserpidine-methyclothiazide). Abbott Pharmaceutical. 2001;PROD.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.